Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging

被引:8
|
作者
Monkman, James [1 ]
Moradi, Afshin [1 ]
Yunis, Joseph [1 ,2 ]
Ivison, Geoff [3 ]
Mayer, Aaron [3 ]
Ladwa, Rahul [4 ]
O'Byrne, Ken [4 ]
Kulasinghe, Arutha [1 ]
机构
[1] Univ Queensland, Frazer Inst, Fac Med, 37 Kent St, Woolloongabba, Qld 4102, Australia
[2] Univ Queensland, Fac Med, Ian Frazer Ctr Childrens Immunotherapy Res, Childrens Hlth Res Ctr, Brisbane, Qld, Australia
[3] Enable Med, Menlo Pk, CA USA
[4] Princess Alexandra Hosp, Brisbane, Qld, Australia
关键词
IMMUNITY;
D O I
10.1186/s12967-024-05035-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The spatial localisation of immune cells within tumours are key to understand the intercellular communications that can dictate clinical outcomes. Here, we demonstrate an analysis pipeline for highly multiplexed CODEX data to phenotype and profile spatial features and interactions in NSCLC patients that subsequently received PD1 axis immunotherapy. We found that regulatory T cells (Tregs) are enriched in non-responding patients and this was consistent with their localization within stromal and peripheral tumour-margins. Proximity-based interactions between Tregs and both monocytes (p = 0.009) and CD8+ T cells (p = 0.009) were more frequently found in non-responding patients, while macrophages were more frequently located in proximity to HLADR+ tumour cells (p = 0.01) within responding patients. Cellular neighbourhoods analysis indicated that both macrophages (p = 0.003) and effector CD4+ T cells (p = 0.01) in mixed tumour neighbourhoods, as well as CD8+ T cells (p = 0.03) in HLADR+ tumour neighbourhoods were associated with favorable clinical response. Evaluation of the inferred regulatory functions between immune cells relative to the tumour suggested that macrophages exhibit an immunosuppressive phenotype against both CD4+ and CD8+ T cells, and that this association scores more highly in ICI refractory patients. These spatial patterns are associated with overall survival in addition to ICI response and may thus indicate features for the functional understanding of the tumour microenvironment.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [22] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [23] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
  • [24] Quantitative Imaging Features Predict Response of Immunotherapy in Non-Small Cell Lung Cancer Patients
    Tunali, Ilke
    Gray, Jhanelle
    Qi, Jin
    Abdullah, Mahmoud
    Balagurunathan, Yoganand
    Gillies, Robert
    Schabath, Matthew
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S474 - S475
  • [25] Response to Immunotherapy in non-small cell lung cancer: the effect of weight
    Fernandes, Ana Luisa
    Dias, Margarida
    Alves, Adelaide
    Coutinho, Daniel
    Silva, Eloisa
    Costa, Telma
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [26] Predicting response to immunotherapy in advanced non-small cell lung cancer
    Rebordao Pires, M.
    Amorim Costa, C.
    Cunha Pereira, T.
    Monteiro, J. C.
    Domingues, I.
    Caetano, A. C.
    Meira Garcia, A. R.
    Jesus, E.
    Sousa, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S768
  • [27] PLATELETS ROLE IN IMMUNOTHERAPY RESPONSE IN NON-SMALL CELL LUNG CANCER
    Colarusso, C.
    Terlizzi, M.
    Pinto, A.
    Sorrentino, R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A22 - A22
  • [28] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [29] Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape
    Vaghani, V.
    Chandwani, S.
    Hirschmann, M.
    Dibaj, S.
    Landry, L. L.
    Roarty, E.
    Zhang, J.
    Rinsurnogkawong, W.
    Lewis, J.
    Lee, J.
    Roth, J. A. Jack A.
    Swisher, S.
    Heymach, J.
    Burke, T.
    Simon, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S901 - S902
  • [30] Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Biomarkers Associated with Early Death
    Munoz Del Toro, Jacobo
    Olmedo, Eugenia
    Gomez, Ana
    Madariaga, Ainhoa
    Perez Templado, Josefa
    Gorospe, Luis
    Reguera, Pablo
    Soria, Ainara
    Gion, Maria
    Martinez, Olga
    Molina, Javier
    Villamayor, Maria
    Saavedra, Cristina
    Munoz, Gema
    Albarran, Victor
    Benito, Amparo
    Barquin, Arantzazu
    Cabanero, Alberto
    Alonso, Teresa
    Gajate, Pablo
    Grande, Enrique
    Garrido, Pilar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1325 - S1326